Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 40 Head & Neck 23 Thoracic 16 Sarcoma 14 Breast 12 Genitourinary 10 CNS 9 Gynecologic 6 Dermatologic 6 Tumor-Agnostic 4 Other neoplasm 1 Endocrine 1

Conditions

Rare Malignant Neoplasm 1

Interventions

Magnetic Resonance Spectroscopy 3 Biopsy 3 fludarabine 2 Taxes 2 Paclitaxel 2 Endoscopic Mucosal Resection 2 Aminolevulinic Acid 2 Albumin-Bound Paclitaxel 2 130-nm albumin-bound paclitaxel 2 venetoclax 1 trametinib 1 toripalimab 1 thymoglobulin 1 taxane 1 sintilimab 1 potassium oxonate 1 lutetium Lu 177 dotatate 1 gimeracil 1 fludarabine phosphate 1 dabrafenib 1 apatinib 1 Whole-Body Irradiation 1 Watchful Waiting 1 Transurethral Resection of Prostate 1 Tegafur 1 Surgical Procedures, Operative 1 Stem Cell Transplantation 1 Standard of Care 1 Specimen Handling 1 Sirolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Surgical Procedures, Operative × Other neoplasm × Clear all

NCT06872853 2025-03-12

RAC

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Rare Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡